Phillips et al., 1979 - Google Patents
The interaction of radiation and bleomycin in intestinal crypt cellsPhillips et al., 1979
- Document ID
- 16232887329537712947
- Author
- Phillips T
- Ross G
- Goldstein L
- Begg A
- Publication year
- Publication venue
- International Journal of Radiation Oncology* Biology* Physics
External Links
Snippet
Using the intestinal crypt cell system, the effects of bleomycin (BLM) with radiation have been determined. The LD 50 60 in LAF, mice used was 167 units/kg and the MTD (LD 01) was 100 units/kg. Survival of crypt cells was reduced to 40% of radiation alone when drug …
- 229960001561 Bleomycin 0 title abstract description 54
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bartelink et al. | Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation | |
| Dombernowsky et al. | Schedule dependency of the antileukemic activity of the podophyllotoxin‐derivative VP 16–213 (NSC‐141540) in L1210 leukemia | |
| Tannock et al. | Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. | |
| Li et al. | Rhenium-188 HEDP to treat painful bone metastases | |
| EP3424561A1 (en) | Boron neutron capture treatingsystem and application of a-amino acid-like boron trifluoride inmanufacturing medicament for treating tumors | |
| Phillips et al. | The interaction of radiation and bleomycin in intestinal crypt cells | |
| RU2160121C2 (en) | Radiation therapy agents containing tin-117m | |
| Hishikawa et al. | High-dose-rate intraluminal brachytherapy (HDRIBT) for esophageal cancer | |
| JPS6234733B2 (en) | ||
| Sherman et al. | The effect of dose rate and adriamycin on the tolerance of thoracic radiation in mice | |
| US6916795B1 (en) | Energy-protective composition comprising adenosine phosphates | |
| CN107224675B (en) | Boron neutron capture therapy system | |
| Phillips et al. | The interaction of radiation and cyclophosphamide in intestinal crypt cells | |
| Maruyama et al. | Neutron brachytherapy is better than conventional radiotherapy in advanced cervical cancer | |
| Van den Bogaert et al. | Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group | |
| Suit et al. | “Oxygen effect” and tumor size as related to response of C3H/Ba adenocarcinoma to local X irradiation | |
| Steel et al. | Protection of mice against fission neutron irradiation by WR-2721 or WR-151327 | |
| Blackett et al. | The enhancement of haemopoietic stem cell recovery in irradiated mice by prior treatment with cyclophosphamide | |
| Cohen et al. | Late reactions and complications in patients treated with high energy neutrons p (66MeV) Be (49MeV) | |
| George et al. | Cytotoxic effect of chlorpromazine and its interaction with radiation on a mouse fibrosarcoma | |
| Lehnert et al. | Dose rate dependence of response of mouse lung to irradiation | |
| Cohen et al. | Experimental evaluation of systemic medication (cysteamine, menadione, flavonoids and corticoids) modifying reactions to radiotherapy | |
| EP2089401B1 (en) | Use of tri-substituted glycerol compounds for the treatment of radiation injuries | |
| EP0392662B1 (en) | Use of complexes of tetrachloroplatinate with a diazo dye as antitumour agents | |
| RU2270045C1 (en) | Method for applying photon-capturing tumor therapy |